Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Citi
Daiichi Sankyo
UBS
Cipla
Teva

Generated: July 20, 2019

DrugPatentWatch Database Preview

Pegfilgrastim - Biologic Drug Details

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for pegfilgrastim

US Patents for pegfilgrastim

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial YALE UNIVERSITY (New Haven, CT) ➤ Try a Free Trial RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for pegfilgrastim

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
006 Luxembourg ➤ Try a Free Trial
5/2003 Austria ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM
00106 Netherlands ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM; NAT. REGISTRATION NO/DATE: EU/1/02/228/001 20020822; FIRST REGISTRATION: EU/1/02/228/001 20020822
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fuji
UBS
Argus Health
Farmers Insurance
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.